{"content":"<li class=\"n-box-item date-title\" data-end=\"1523505599\" data-start=\"1523419200\" data-txt=\"Monday, December 23, 2019\">Wednesday, April 11, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3345124\" data-ts=\"1523486827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLCM\" target=\"_blank\">BLCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345124-bellicumplus-18_3-fda-lifts-clinical-hold-on-bpxminus-501-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bellicum +18.3% as FDA lifts clinical hold on BPX-501 studies</a></h4><ul>   <li>Bellicum Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a>) is soaring after hours, <font color='green'>up 18.3%</font>, after the company says the FDA <a href=\"https://seekingalpha.com/pr/17127231-bellicum-announces-clinical-hold-lifted-u-s-studies-bpxminus-501\" target=\"_blank\">lifted a clinical hold</a> on studies of its BPX-501 in the United States.</li>    <li>The company says it's working with U.S. clinical sites to resume patient recruited based on protocols it amended in consultation with the FDA, including guidance on monitoring and management of neurologic adverse events.</li>    <li>BPX-501 is an adjunct T-cell therapy administered after allogeneic HSCT, comprising genetically modified donor T cells incorporating Bellicum&rsquo;s CaspaCIDe safety switch. The therapy may enable physicians to more safely perform stem cell transplants.</li>    <li>The clinical hold didn't affect the BP-004 trial in Europe, which is fully enrolled, the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345124\" data-linked=\"Bellicum +18.3% as FDA lifts clinical hold on BPX-501 studies\" data-tweet=\"$BLCM - Bellicum +18.3% as FDA lifts clinical hold on BPX-501 studies https://seekingalpha.com/news/3345124-bellicumplus-18_3-fda-lifts-clinical-hold-on-bpxminus-501-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3345124-bellicumplus-18_3-fda-lifts-clinical-hold-on-bpxminus-501-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345122\" data-ts=\"1523486337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345122-polarityteminus-8-on-report-of-offering-priced-15-16-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolarityTE -8% on report of offering priced at $15-$16/share</a></h4><ul>   <li>PolarityTE (COOL) is <font color='red'>down 8%</font> after Bloomberg says its share offering will be priced at $15-$16/share.</li>    <li>The stock closed <font color='red'>down 4.2%</font> in the regular session, to $18.31; it's moving at $16.85 postmarket.</li>    <li>Cantor Fitzgerald is running the offering, proceeds of which will go toward R&amp;D and commercialization, registration or approval of products and candidates.</li><li><strong>Update</strong>: The <a href=\"https://seekingalpha.com/pr/17128079-polarityte-announces-pricing-public-offering-common-stock\" target=\"_blank\">offering</a> is ~2M shares of common stock at $16. Underwriters over-allotment is an additional ~305K shares. Closing date is April 16.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345122\" data-linked=\"PolarityTE -8% on report of offering priced at $15-$16/share\" data-tweet=\"$PTE - PolarityTE -8% on report of offering priced at $15-$16/share https://seekingalpha.com/news/3345122-polarityteminus-8-on-report-of-offering-priced-15-16-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3345122-polarityteminus-8-on-report-of-offering-priced-15-16-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345121\" data-ts=\"1523486104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345121-novavaxminus-11_1-on-report-of-25m-share-offering-1_65\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax -11.1% on report of 25M-share offering at $1.65</a></h4><ul>   <li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) is <font color='red'>11.1% lower</font> on heavy postmarket volume after word that its <a href=\"https://seekingalpha.com/news/3345087-novavax-readies-stock-offering\" target=\"_blank\">planned stock offering</a> will number 25M shares coming at $1.65/share, according to Bloomberg.</li>    <li>The stock closed at $2.08 today and is moving at $1.85 in postmarket action.</li>    <li>The offering will be used for general purposes; it's coming via Citi and Piper Jaffray.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345121\" data-linked=\"Novavax -11.1% on report of 25M-share offering at $1.65\" data-tweet=\"$NVAX - Novavax -11.1% on report of 25M-share offering at $1.65 https://seekingalpha.com/news/3345121-novavaxminus-11_1-on-report-of-25m-share-offering-1_65?source=tweet\" data-url=\"https://seekingalpha.com/news/3345121-novavaxminus-11_1-on-report-of-25m-share-offering-1_65\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345114\" data-ts=\"1523482672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXTI\" target=\"_blank\">AXTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345114-axtiminus-15-after-cutting-q1-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AXTI -15% after cutting Q1 revenue guidance</a></h4><ul>     <li>AXTI Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a>) <font color='red'>-15%</font> after-hours as it <a href=\"https://seekingalpha.com/pr/17127288-axt-inc-updates-expectations-first-quarter-2018\" target=\"_blank\">lowers its Q1 revenue guidance</a> to $24M-$24.5M from its February outlook of $26M-$27M, citing government ordered factory shutdowns in Beijing caused by severe air pollution that occurred late in the quarter.</li>     <li>AXTI says manufacturing companies in the area were intermittently shut down for a total of 10 days between Feb. 27 and March 31, but the company says demand for its compound semiconductor substrates \"remains solid.\"</li>     <li>AXTI also says it has completed the first phase of facilitization of the new manufacturing facility in Dingxing, China.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345114\" data-linked=\"AXTI -15% after cutting Q1 revenue guidance\" data-tweet=\"$AXTI - AXTI -15% after cutting Q1 revenue guidance https://seekingalpha.com/news/3345114-axtiminus-15-after-cutting-q1-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3345114-axtiminus-15-after-cutting-q1-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345113\" data-ts=\"1523482490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QNST\" target=\"_blank\">QNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345113-after-hours-gainers-losers-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (04/11/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/QNST' title='QuinStreet, Inc.'>QNST</a> <font color='green'>+20.9%</font>. <a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a> <font color='green'>+15.3%</font>. <a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a>&nbsp;<font color='green'>+4.3%</font>. <a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a>&nbsp;<font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/FTI' title='TechnipFMC plc'>FTI</a>&nbsp;<font color='green'>+1.4%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='red'>-13.2%</font>. <a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a> <font color='red'>-10.1%</font>. <a href='https://seekingalpha.com/symbol/AGX' title='Argan, Inc.'>AGX</a>&nbsp;<font color='red'>-4.4%.&nbsp;</font><a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a>&nbsp;<font color='red'>-4.3%</font>. GFA&nbsp;<font color='red'>-3.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345113\" data-linked=\"After Hours Gainers / Losers (04/11/2018)\" data-tweet=\"$QNST $QNST $BLCM - After Hours Gainers / Losers (04/11/2018) https://seekingalpha.com/news/3345113-after-hours-gainers-losers-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3345113-after-hours-gainers-losers-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345112\" data-ts=\"1523481985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345112-bed-bath-beyondminus-14-after-guiding-full-year-earnings-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond -14% after guiding full-year earnings below consensus</a></h4><ul>     <li>Bed Bath &amp;&nbsp;Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color='red'>-14.3%</font> after-hours as <a href=\"https://seekingalpha.com/news/3345092-bed-bath-and-beyond-beats-0_08-beats-revenue\" target=\"_blank\">Q4 results</a> at the housewares chain show disappointing same-store sales as well as a <a href=\"https://www.bloomberg.com/news/articles/2018-04-11/bed-bath-beyond-plunges-after-posting-gloomy-annual-forecast\" target=\"_blank\">bleak outlook</a> for the current year.</li>     <li>BBBY says Q4 EPS of $1.48 beat analyst consensus expectations but fell sharply from $1.84 in the year-ago period, sales rose 5.2% Y/Y to $3.7B to finish in-line with expectations, and same-store sales fell 0.6%, which was less severe than the consensus for a 2.3% drop.</li>     <li>But the company issues downside earnings guidance for FY 2019, seeing EPS in the low-to-mid $2 range vs. $2.77 analyst consensus estimate.</li>     <li>BBBY also raises its quarterly dividend to $0.16/share from $0.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345112\" data-linked=\"Bed Bath &amp; Beyond -14% after guiding full-year earnings below consensus\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond -14% after guiding full-year earnings below consensus https://seekingalpha.com/news/3345112-bed-bath-beyondminus-14-after-guiding-full-year-earnings-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3345112-bed-bath-beyondminus-14-after-guiding-full-year-earnings-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345108\" data-ts=\"1523480869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DQ\" target=\"_blank\">DQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345108-daqo-new-energy-to-offer-2m-adss-in-follow-on-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daqo New Energy to offer 2M ADSs in follow-on offering</a></h4><ul>     <li>Daqo New Energy (NYSE:<a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a>) <font color='red'>-5.1%</font> after-hours following news of a <a href=\"https://seekingalpha.com/pr/17127143-daqo-new-energy-corp-announces-proposed-follow-public-offering-american-depositary-shares\" target=\"_blank\">public offering</a> of 2M American Depositary Shares, with an underwriters option to purchase up to 300K additional ADSs.</li>     <li>DQ says it plans to use the net proceeds for general corporate purposes, including capital expenditure for further capacity expansion and upgrade of its business, as well as working capital.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345108\" data-linked=\"Daqo New Energy to offer 2M ADSs in follow-on offering\" data-tweet=\"$DQ - Daqo New Energy to offer 2M ADSs in follow-on offering https://seekingalpha.com/news/3345108-daqo-new-energy-to-offer-2m-adss-in-follow-on-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3345108-daqo-new-energy-to-offer-2m-adss-in-follow-on-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345104\" data-ts=\"1523480066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345104-globalstarplus-6_4-mudrick-goes-to-active-stake-offers-150m-financing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globalstar +6.4% as Mudrick goes to active stake, offers $150M financing</a></h4><ul>   <li>Shares of Globalstar (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a>) that ended today <font color='green'>up 13.6%</font> are another <font color='green'>6.4% higher</font> after hours, following a late filing converting a <a href=\"https://seekingalpha.com/filing/3973766\" target=\"_blank\">passive stake to an active stake</a> taken by Mudrick Capital Management.</li>    <li>Jason Mudrick's funds hold 5.6% of outstanding stock, and delivered a <a href=\"https://www.sec.gov/Archives/edgar/data/1366868/000092189518001270/ex992to13d11509001glo_041118.pdf\" target=\"_blank\">letter</a> to Globalstar's board to say the stock is \"deeply undervalued and to recommend value-enhancing options that would maximize the benefit to all shareholders.\"</li>    <li>It also said Mudrick is willing to lend $150M in nonconvertible financing to help address capital needs through 2019, and would welcome other shareholders joining in. (The letter also said Mudrick wouldn't support seeking additional financing from controlling shareholder Thermo Companies.)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345015-morgan-stanley-starts-globalstar-equal-weight\" target=\"_blank\">Morgan Stanley starts Globalstar at Equal Weight</a> (Apr. 11 2018)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3345104\" data-linked=\"Globalstar +6.4% as Mudrick goes to active stake, offers $150M financing\" data-tweet=\"$GSAT - Globalstar +6.4% as Mudrick goes to active stake, offers $150M financing https://seekingalpha.com/news/3345104-globalstarplus-6_4-mudrick-goes-to-active-stake-offers-150m-financing?source=tweet\" data-url=\"https://seekingalpha.com/news/3345104-globalstarplus-6_4-mudrick-goes-to-active-stake-offers-150m-financing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345102\" data-ts=\"1523479768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345102-neovasc-raises-7_1m-from-warrant-exercises-shares-up-12-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc raises $7.1M from warrant exercises; shares up 12% after hours</a></h4><ul><li>Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) <a href=\"https://seekingalpha.com/pr/17127260-neovasc-announces-receipt-us-7_1-million-exercise-series-c-warrants\" target=\"_blank\">announces </a>that it has received ~$7.1M from the exercise of ~4.9M Series C warrants by investors.</li><li>Each Series C Warrant entitled the holder to receive one Series C Unit, consisting of one share of common stock, one Series A Warrant and one Series B Warrant.</li><li>Shares are up&nbsp;<font color='green'>12%&nbsp;</font>after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3311059-neovasc-prices-equity-offering-shares-10-percent-premarket\" target=\"_blank\">Neovasc prices equity offering; shares down 10% premarket</a> (Nov. 10, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3345102\" data-linked=\"Neovasc raises $7.1M from warrant exercises; shares up 12% after hours\" data-tweet=\"$NVCN - Neovasc raises $7.1M from warrant exercises; shares up 12% after hours https://seekingalpha.com/news/3345102-neovasc-raises-7_1m-from-warrant-exercises-shares-up-12-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3345102-neovasc-raises-7_1m-from-warrant-exercises-shares-up-12-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345091\" data-ts=\"1523477983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QNST\" target=\"_blank\">QNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345091-quinstreet-reports-preliminary-q3-results-above-expectation-sharesplus-10-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QuinStreet reports preliminary Q3 results above expectation; shares +10% AH</a></h4><ul>     <li>QuinStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/QNST' title='QuinStreet, Inc.'>QNST</a>) expects to report revenue of over $115M (+45% Y/Y) vs. a consensus of $91.86M.</li>     <li>Adjusted EBITDA is expected to be greater than 8%.</li>     <li>&ldquo;Our strong and improving financial performance continues to be driven by good results for our clients and media partners, and by our significant competitive advantages,&rdquo; commented Doug Valenti, CEO of QuinStreet.</li>     <li>The Company expects positive business momentum to continue.</li>     <li>The Company will announce its results on May 01, 2018.</li><li>Shares&nbsp;<font color='green'>+10% AH</font></li><li><a href=\"https://seekingalpha.com/pr/17127185-quinstreet-announces-preliminary-third-quarter-fiscal-2018-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3345091\" data-linked=\"QuinStreet reports preliminary Q3 results above expectation; shares +10% AH\" data-tweet=\"$QNST - QuinStreet reports preliminary Q3 results above expectation; shares +10% AH https://seekingalpha.com/news/3345091-quinstreet-reports-preliminary-q3-results-above-expectation-sharesplus-10-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/3345091-quinstreet-reports-preliminary-q3-results-above-expectation-sharesplus-10-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345087\" data-ts=\"1523477256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345087-novavax-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax readies stock offering</a></h4><ul><li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) <a href=\"https://seekingalpha.com/pr/17127149-novavax-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345087\" data-linked=\"Novavax readies stock offering\" data-tweet=\"$NVAX - Novavax readies stock offering https://seekingalpha.com/news/3345087-novavax-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3345087-novavax-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345084\" data-ts=\"1523477116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345084-polarityte-launches-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolarityTE launches stock offering</a></h4><ul><li>PolarityTE (COOL) <a href=\"https://seekingalpha.com/pr/17127145-polarityte-announces-public-offering-common-stock\" target=\"_blank\">commences </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345084\" data-linked=\"PolarityTE launches stock offering\" data-tweet=\"$PTE - PolarityTE launches stock offering https://seekingalpha.com/news/3345084-polarityte-launches-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3345084-polarityte-launches-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345081\" data-ts=\"1523476118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345081-pretium-resourcesplus-19-brucejack-mine-production-surges-in-march\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pretium Resources +19% as Brucejack mine production surges in March</a></h4><ul>     <li>Pretium Resources (<a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='green'>+19.5%</font>) powers higher after reporting a <a href=\"https://seekingalpha.com/pr/17126037-pretium-resources-inc-brucejack-mine-q1-2018-production-update\" target=\"_blank\">production surge in March</a> at its Brucejack mine in British Columbia, with 32.9K oz. in March to cap total Q1 production of nearly 75.7K oz.</li>     <li>PVG says it expects to meet its H1 production target for Brucejack of 150K-200K oz. as well as cost guidance of $700-$900/oz.</li>     <li>PVG attributes the March production surge to the \"successful implementation of a number of operational improvement initiatives,\" including the first impact of grade control integration into the mining process, and it expects production to continue to improve during Q2 with the full integration of the grade control program.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345081\" data-linked=\"Pretium Resources +19% as Brucejack mine production surges in March\" data-tweet=\"$PVG - Pretium Resources +19% as Brucejack mine production surges in March https://seekingalpha.com/news/3345081-pretium-resourcesplus-19-brucejack-mine-production-surges-in-march?source=tweet\" data-url=\"https://seekingalpha.com/news/3345081-pretium-resourcesplus-19-brucejack-mine-production-surges-in-march\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345076\" data-ts=\"1523474547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345076-finisar-lumentum-ride-rosenblatts-applied-opto-commentary-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar, Lumentum ride Rosenblatt&#39;s Applied Opto commentary higher</a></h4><ul>   <li>Optical networking peers are following Applied Optoelectronics (<a href=\"http://seekingalpha.com/symbol/AAOI\" target=\"_blank\">AAOI</a> <font color='green'>+14.8%</font>) higher after that company's surge fueled by <a href=\"https://seekingalpha.com/news/3345016-applied-optoelectronics-plus-10-percent-following-rosenblatt-commentary\" target=\"_blank\">bullish Rosenblatt commentary</a>.</li>    <li>Like Applied Opto, Lumentum (<a href=\"http://seekingalpha.com/symbol/LITE\" target=\"_blank\">LITE</a> <font color='green'>+4.6%</font>) and Finisar (<a href=\"http://seekingalpha.com/symbol/FNSR\" target=\"_blank\">FNSR</a> <font color='green'>+2.1%</font>) are set to use pricing and quality advantages to take some share in hyperscale CWDM4 demand, analyst Jun Zhang says.</li>    <li>The weakness at other competitors is giving Applied Opto the chance to build momentum at Facebook and Amazon, Rosenblatt notes.</li>    <li>Finisar and Lumentum are each at their highest point in two weeks. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>, meanwhile, is up double digits to its highest point since mid-March.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345076\" data-linked=\"Finisar, Lumentum ride Rosenblatt&#39;s Applied Opto commentary higher\" data-tweet=\"$AAOI $AAOI $LITE - Finisar, Lumentum ride Rosenblatt&#39;s Applied Opto commentary higher https://seekingalpha.com/news/3345076-finisar-lumentum-ride-rosenblatts-applied-opto-commentary-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3345076-finisar-lumentum-ride-rosenblatts-applied-opto-commentary-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345075\" data-ts=\"1523474452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345075-gold-fields-to-decide-on-salares-norte-mine-in-chile-next-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields to decide on Salares Norte mine in Chile next year</a></h4><ul>     <li>Gold Fields (<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+3.4%</font>) likely will <a href=\"https://www.reuters.com/article/us-chile-mining-gold-fields/cru-cesco-gold-fields-to-make-decision-on-chile-gold-mine-next-year-idUSKBN1HI2W4\" target=\"_blank\">decide next year</a> whether to commit to $850M toward construction of the Salares Norte project in Chile's Andes Mountains, Alberto Cardenas, the company's VP for operations in the Americas, tells Reuters.</li>     <li>Assuming the project gets the go-ahead, Cardenas says he expected production to begin around 2021 and quickly achieve target output of 345K oz./year of gold.</li>     <li>GFI also is investing in a new mine in Australia and upgrades at mines in Ghana and Peru.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345075\" data-linked=\"Gold Fields to decide on Salares Norte mine in Chile next year\" data-tweet=\"$GFI - Gold Fields to decide on Salares Norte mine in Chile next year https://seekingalpha.com/news/3345075-gold-fields-to-decide-on-salares-norte-mine-in-chile-next-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3345075-gold-fields-to-decide-on-salares-norte-mine-in-chile-next-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345072\" data-ts=\"1523473975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345072-hcc-settlement-no-bearing-on-hiiq-probe-capitol-forum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCC settlement no bearing on HIIQ probe - Capitol Forum</a></h4><ul><li>The California Department of Insurance<a href=\"https://thecapitolforum.com/\" target=\"_blank\"> tells Capitol Forum</a> last night's announced deal with HCC will have no bearing on the continuing multi-state probe of Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a>).</li><li>Shares nevertheless remain&nbsp;<font color='green'>higher by 4.8%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344998-health-insurance-innovations-6-percent\" target=\"_blank\">Health Insurance Innovations up 6%</a> (April 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3345072\" data-linked=\"HCC settlement no bearing on HIIQ probe - Capitol Forum\" data-tweet=\"$HIIQ - HCC settlement no bearing on HIIQ probe - Capitol Forum https://seekingalpha.com/news/3345072-hcc-settlement-no-bearing-on-hiiq-probe-capitol-forum?source=tweet\" data-url=\"https://seekingalpha.com/news/3345072-hcc-settlement-no-bearing-on-hiiq-probe-capitol-forum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345070\" data-ts=\"1523473240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGRY\" target=\"_blank\">SGRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345070-surgery-partners-down-7-stifel-trims-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Surgery Partners down 7% as Stifel trims price target</a></h4><ul><li>via Bloomberg</li><li>A pricey valuation with 2018 setting up to be a difficult year makes for a bad combination, says analyst Chad Vanacore, cutting his price target on Surgery Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a>) to $15 from $17.</li><li>He notes consensus forecasts remain higher than soft management guidance.</li><li>Shares are<font color='red'> down 7.3%</font>&nbsp;to $16.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345070\" data-linked=\"Surgery Partners down 7% as Stifel trims price target\" data-tweet=\"$SGRY - Surgery Partners down 7% as Stifel trims price target https://seekingalpha.com/news/3345070-surgery-partners-down-7-stifel-trims-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3345070-surgery-partners-down-7-stifel-trims-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345069\" data-ts=\"1523473223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEDS\" target=\"_blank\">LEDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345069-technology-top-5-gainers-losers-of-3-00-pm-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology  - Top 5 Gainers / Losers as of 3:00 PM (04/11/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+54%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/POLA' title='Polar Power Inc'>POLA</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/QNST' title='QuinStreet, Inc.'>QNST</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345069\" data-linked=\"Technology  - Top 5 Gainers / Losers as of 3:00 PM (04/11/2018)\" data-tweet=\"$LEDS $LEDS $AAOI - Technology - Top 5 Gainers / Losers as of 3:00 PM (04/11/2018) https://seekingalpha.com/news/3345069-technology-top-5-gainers-losers-of-3-00-pm-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3345069-technology-top-5-gainers-losers-of-3-00-pm-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345061\" data-ts=\"1523471552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345061-t-crown-castle-expand-long-term-leasing-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T, Crown Castle expand long-term leasing deal</a></h4><ul>   <li>AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-1.3%</font>) and Crown Castle (<a href=\"http://seekingalpha.com/symbol/CCI\" target=\"_blank\">CCI</a> <font color='green'>+2.3%</font>) have entered a <a href=\"https://seekingalpha.com/pr/17126675-t-crown-castle-expand-strategic-relationship\" target=\"_blank\">new agreement</a> they say streamlines lease management and operations, with AT&amp;T focused on the speed of deployment of 5G technology and its FirstNet public safety network.</li>    <li>Along with macro sites, the new agreement covers small cells and looks to hit a pain point AT&amp;T has had with older tower leasing models.</li>    <li>It's a \"significant milestone,\" says AT&amp;T's Susan Johnson: \"It establishes a market-based framework and simplifies the lease management and administration process. This will allow us to streamline network projects to better serve our customers.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345061\" data-linked=\"AT&amp;T, Crown Castle expand long-term leasing deal\" data-tweet=\"$T $T $CCI - AT&amp;T, Crown Castle expand long-term leasing deal https://seekingalpha.com/news/3345061-t-crown-castle-expand-long-term-leasing-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3345061-t-crown-castle-expand-long-term-leasing-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345060\" data-ts=\"1523471379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345060-fomc-minutes-lean-hawkish-dollar-strengthens-gold-slips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FOMC minutes lean hawkish; dollar strengthens, gold slips</a></h4><ul><li>\"Some\" participants suggested a future policy statement change could be necessary to acknowledge that monetary policy at some point might have to move to a neutral or even restrictive stance (it currently continues to be considered accommodative).</li><li>All members judge recent data and other developments as showing the economy had strengthened in recent months. That and inflation expected to soon return to 2% might mean a \"slightly steeper\" path of rate hikes than currently expected.</li><li><a href=\"https://www.federalreserve.gov/monetarypolicy/fomcminutes20180321.htm\" target=\"_blank\">FOMC Minutes from March 20-21</a></li><li>Stocks remain little-changed, and the 10-year Treasury yield continues to be modestly lower on the session. The dollar (NYSEARCA:<a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>) has erased its losses, now flat on the day. Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) has erased some gains, now&nbsp;<font color='green'>up just 0.45%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345060\" data-linked=\"FOMC minutes lean hawkish; dollar strengthens, gold slips\" data-tweet=\"$UUP $GLD - FOMC minutes lean hawkish; dollar strengthens, gold slips https://seekingalpha.com/news/3345060-fomc-minutes-lean-hawkish-dollar-strengthens-gold-slips?source=tweet\" data-url=\"https://seekingalpha.com/news/3345060-fomc-minutes-lean-hawkish-dollar-strengthens-gold-slips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345058\" data-ts=\"1523470377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345058-jet-fuel-price-concerns-clip-airline-majors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jet fuel price concerns clip airline majors</a></h4><ul><li>U.S. airline stocks are lower for a second consecutive day on concerns that higher crude oil prices could impact earnings.</li><li>No-hedging American Airlines Group (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color='red'>-2.9%</font>) and United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='red'>-2.5%</font>) in particular are at risk of needing to adjust guidance, while Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='red'>-0.6%</font>) hopes to reap the benefit of owning a refinery during a period of rising oil prices.</li><li>Across the industry, jet fuel and employee wages are the top two expenses for airlines.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344976-airline-fares-second-month-row\" target=\"_blank\">Airline fares up for second month in a row</a> (April 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3345058\" data-linked=\"Jet fuel price concerns clip airline majors\" data-tweet=\"$AAL $AAL $UAL - Jet fuel price concerns clip airline majors https://seekingalpha.com/news/3345058-jet-fuel-price-concerns-clip-airline-majors?source=tweet\" data-url=\"https://seekingalpha.com/news/3345058-jet-fuel-price-concerns-clip-airline-majors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345056\" data-ts=\"1523469603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345056-energy-materials-top-gainers-losers-of-2-00-pm-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/11/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/NRP' title='Natural Resource Partners LP'>NRP</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/EC' title='Ecopetrol S.A.'>EC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+8%</font>.</li> &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3345056\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/11/2018)\" data-tweet=\"$PVG $PVG $NRP - Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/11/2018) https://seekingalpha.com/news/3345056-energy-materials-top-gainers-losers-of-2-00-pm-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3345056-energy-materials-top-gainers-losers-of-2-00-pm-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345054\" data-ts=\"1523468687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345054-biogen-up-1-on-potential-sale-of-part-of-bioepis-stake-to-samsung-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen up 1% on potential sale of part of Bioepis stake to Samsung Group</a></h4><ul><li>Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='green'>+1.2%</font>) is up modestly, albeit on light volume, on the heels of <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/04/11503890/mizuho-samsung-bioepis-renegotiation-a-positive-for-bio\" target=\"_blank\">reports</a> that Samsung Group is in discussions to acquire at least 30% of Biogen's stake in Samsung Bioepis, a joint venture formed in 2011 between the Cambridge, MA-based biotech and Samsung BioLogics aimed at developing biosimilars.</li><li>Biogen's current stake is only 5.4% but it owns a call option allowing it to increase its ownership to 49.9%. It can exercise the call at any time within the exercise period by paying 50K won (US$47) per share or a total of ~US$421M.</li><li>According to <a href=\"http://www.businesskorea.co.kr/english/21587-foray-pharma-business-samsung-begins-talks-biogen-secure-control-biosimilar-joint-venture\" target=\"_blank\">Business Korea</a>, Samsung Group is considering raising 3T won (US$2.81B) to finance the deal. If all goes as planned, Samsung BioLogics will hold a 50% stake, Samsung Group holding company Samsung C&amp;T will hold 30% followed by Biogen with 20%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345054\" data-linked=\"Biogen up 1% on potential sale of part of Bioepis stake to Samsung Group\" data-tweet=\"$BIIB - Biogen up 1% on potential sale of part of Bioepis stake to Samsung Group https://seekingalpha.com/news/3345054-biogen-up-1-on-potential-sale-of-part-of-bioepis-stake-to-samsung-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3345054-biogen-up-1-on-potential-sale-of-part-of-bioepis-stake-to-samsung-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345034\" data-ts=\"1523467838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MIND\" target=\"_blank\">MIND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345034-mitcham-industries-down-2-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mitcham Industries down 2% post Q4 results</a></h4><ul><li>Mitcham Industries (<a href='https://seekingalpha.com/symbol/MIND' title='Mitcham Industries, Inc.'>MIND</a> <font color='red'>-2.3%</font>) reported Q4 revenue decline of 17.5%Y/Y to $10.4M. Segment revenues: Marine technology products -37.5%Y/Y to $5M; Equipment leasing -13.6% Y/Y to $2.06M and Lease pool -1% to $3.31M.</li><li>Q4 Margins: Gross<font color='green'> recovered by 3,450&nbsp;</font>to 13.23%, Operating&nbsp;<font color='red'>declined by 285 bps</font>&nbsp;to 74% and Adjusted EBITDA<font color='red'> declined by 3,149 bps</font>&nbsp;to -11.16%.</li><li>Segment gross margins: Marine technology&nbsp;<font color='red'>declined by 2,272 bps</font>&nbsp;to 25.6% and Equipment leasing segment&nbsp;<font color='green'>recovered 10,607 bps&nbsp;</font>to 1.7%.</li><li>\"Mitcham's capital structure remains solid with no debt on our balance sheet and ample liquidity, with cash and cash equivalents of $9.9 million as of January 31, 2018. In addition, we generated positive cash flow from operating activities over the course of fiscal 2018,\" said Cp-CEO Robb Capps.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344806-mitcham-misses-0_07-misses-revenue\" target=\"_blank\">Mitcham misses by $0.07, misses on revenue</a> (April 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3345034\" data-linked=\"Mitcham Industries down 2% post Q4 results\" data-tweet=\"$MIND - Mitcham Industries down 2% post Q4 results https://seekingalpha.com/news/3345034-mitcham-industries-down-2-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3345034-mitcham-industries-down-2-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345052\" data-ts=\"1523467760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLNT\" target=\"_blank\">FLNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345052-cogint-announces-corporate-name-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cogint Announces Corporate Name Change</a></h4><ul>     <li>Cogint (COGT <font color='green'>+10.9%</font>) announced it will change its name to Fluent, Inc.</li>     <li>Trading on NASDAQ under the new Fluent, Inc. name, ticker symbol &ldquo;FLNT&rdquo; and new CUSIP number 34380C 102 is expected to begin at market open on Monday, April 16, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343416-cogint-adds-former-epsilon-ceo-board\" target=\"_blank\">Cogint adds former Epsilon CEO to board</a> (April 3)</li>     <li><a href=\"https://seekingalpha.com/pr/17126398-cogint-inc-announces-corporate-name-change-fluent-inc\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3345052\" data-linked=\"Cogint Announces Corporate Name Change\" data-tweet=\"$FLNT - Cogint Announces Corporate Name Change https://seekingalpha.com/news/3345052-cogint-announces-corporate-name-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3345052-cogint-announces-corporate-name-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345049\" data-ts=\"1523466128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLT\" target=\"_blank\">HLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345049-hotel-stocks-rally-after-positive-pricing-trend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hotel stocks rally after positive pricing trend</a></h4><ul><li>Hilton Worldwide Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HLT' title='Hilton Worldwide Holdings'>HLT</a>) is&nbsp;<font color='green'>up 5.80%</font>&nbsp;after consumer price data released today showed a healthy gain for hotel and motel rates during the month of March.</li><li>Choice Hotels International (<a href='https://seekingalpha.com/symbol/CHH' title='Choice Hotels International, Inc.'>CHH</a> <font color='green'>+2.2%</font>), Wyndham Worldwide (<a href='https://seekingalpha.com/symbol/WYN' title='Wyndham Worldwide Corporation'>WYN</a> <font color='green'>+2.2%</font>) and Hyatt Hotels (<a href='https://seekingalpha.com/symbol/H' title='Hyatt Hotels Corporation'>H</a> <font color='green'>+2%</font>) are all also posting solid gains.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344981-u-s-hotel-rates-track-higher\" target=\"_blank\">U.S. hotel rates track higher</a> (April 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3345049\" data-linked=\"Hotel stocks rally after positive pricing trend\" data-tweet=\"$HLT $HLT $CHH - Hotel stocks rally after positive pricing trend https://seekingalpha.com/news/3345049-hotel-stocks-rally-after-positive-pricing-trend?source=tweet\" data-url=\"https://seekingalpha.com/news/3345049-hotel-stocks-rally-after-positive-pricing-trend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345048\" data-ts=\"1523466037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHLR\" target=\"_blank\">WHLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345048-financials-top-gainers-losers-of-1-00-pm-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (04/11/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CURO' title='CURO Group Holdings Corp.'>CURO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345048\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (04/11/2018)\" data-tweet=\"$WHLR $WHLR $CURO - Financials - Top Gainers / Losers as of 1:00 PM (04/11/2018) https://seekingalpha.com/news/3345048-financials-top-gainers-losers-of-1-00-pm-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3345048-financials-top-gainers-losers-of-1-00-pm-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345046\" data-ts=\"1523465822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345046-variety-apple-music-40m-subscribers-gets-new-worldwide-head\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Variety: Apple Music has 40M subscribers, gets new worldwide head</a></h4><ul><li>        <a href=\"http://variety.com/2018/music/news/apple-music-40-million-subscribers-oliver-schusser-1202750066/\" target=\"_blank\">Variety reports</a> that Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) has promoted Oliver Schusser to become head of Apple Music Worldwide.</li><li>               Schusser has worked on overseas promotions of the App Store, iTunes&rsquo; movies and TV, iBooks, and more and played a key role in the Shazam acquisition.&nbsp;</li><li>               His official title will be VP of Apple Music &amp; International Content and he will report to Eddy Cue. &nbsp;&nbsp;</li><li>               Apple market exec Tracey Hannelly will step into the vacated international leadership role.&nbsp;</li><li>           Variety found out the news from an internal memo that also revealed that Apple Music now has over 40M paid subscribers in 115 countries.  </li><li>Apple shares are<font color='red'> down 0.2%</font>.&nbsp; &nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340725-new-iphone-x-cost-apple-10-percent-less-iovine-stepping-back-music\" target=\"_blank\">New iPhone X could cost Apple 10% less; Iovine stepping back from Music</a> (March 21)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341443-apple-music-virtual-record-label\" target=\"_blank\">Apple Music... virtual record label?</a> (March 26)</li></ul> &nbsp;<br /><div class=\"tiny-share-widget\" data-id=\"3345046\" data-linked=\"Variety: Apple Music has 40M subscribers, gets new worldwide head\" data-tweet=\"$AAPL - Variety: Apple Music has 40M subscribers, gets new worldwide head https://seekingalpha.com/news/3345046-variety-apple-music-40m-subscribers-gets-new-worldwide-head?source=tweet\" data-url=\"https://seekingalpha.com/news/3345046-variety-apple-music-40m-subscribers-gets-new-worldwide-head\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345043\" data-ts=\"1523465423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEDS\" target=\"_blank\">LEDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345043-midday-gainers-losers-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (04/11/2018)</a></h4><ul>     <li><strong>Gainers:</strong><a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AMRH' title='Ameri Holdings, Inc.'>AMRH</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+12%</font>.</li><li><strong>Losers:</strong><a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/QNST' title='QuinStreet, Inc.'>QNST</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma'>NTEC</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ALOG' title='Analogic Corporation'>ALOG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/NCNA' title='NuCana plc'>NCNA</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CARG' title='CarGurus, Inc.'>CARG</a> <font color='red'>-8%</font>.</li> &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3345043\" data-linked=\"Midday Gainers / Losers (04/11/2018)\" data-tweet=\"$LEDS $LEDS $PVG - Midday Gainers / Losers (04/11/2018) https://seekingalpha.com/news/3345043-midday-gainers-losers-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3345043-midday-gainers-losers-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345042\" data-ts=\"1523465041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GS\" target=\"_blank\">GS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345042-stress-test-disappointment-for-banks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stress test disappointment for banks</a></h4><ul><li>The Fed<a href=\"https://www.federalreserve.gov/newsevents/pressreleases/bcreg20180410a.htm\" target=\"_blank\"> last night announced</a> proposed changes to its annual stress test procedures. It's been widely assumed that any changes would be bank-friendly, but while banks are sure to like some of the new rules, a new \"stress capital buffer\" <a href=\"https://www.wsj.com/articles/the-feds-new-rules-are-a-letdown-for-wall-street-1523462199?mod=searchresults&amp;page=1&amp;pos=1\" target=\"_blank\">might raise capital requirements</a> for certain lenders.</li><li>The previous rule said banks needed a fixed buffer of 2.5% of risk-weighted assets, but the new proposal only sets 2.5% as a floor - meaning it could go higher.</li><li>Nomura's Steven Chubak estimates Goldman Sachs (<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a> <font color='red'>-1.2%</font>) and Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='red'>-1.8%</font>) might each have to retain additional capital thanks to the changes. More commercially-focused banks like Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='red'>-0.3%</font>), Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-1.3%</font>), and JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-0.9%</font>) should be less affected.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345042\" data-linked=\"Stress test disappointment for banks\" data-tweet=\"$GS $GS $MS - Stress test disappointment for banks https://seekingalpha.com/news/3345042-stress-test-disappointment-for-banks?source=tweet\" data-url=\"https://seekingalpha.com/news/3345042-stress-test-disappointment-for-banks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345031\" data-ts=\"1523462860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BVXV\" target=\"_blank\">BVXV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345031-biondvax-up-3-on-start-of-mid-stage-study-of-flu-vaccine-mminus-001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BiondVax up 3% on start of mid-stage study of flu vaccine M-001</a></h4><ul><li>Thinly traded BiondVax (<a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a> <font color='green'>+3.4%</font>) is up on modestly higher volume, albeit on turnover of only 15.5K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17126217-biondvax-begins-nih-sponsored-phase-2-clinical-trial-universal-flu-vaccine-united-states\" target=\"_blank\">announcement </a>that enrollment is underway in an NIAID-sponsored Phase 2 clinical trial evaluating universal flu vaccine candidate M-001.</li><li>The study will enroll 120 subjects who will be randomized to receive two doses of M-001 or two doses of placebo. A few months later, all participants will receive a currently marketed un-adjuvanted quadrivalent flu vaccine. Safety and immunogenicity will be assessed and compared between the M-001 and placebo cohorts.</li><li>A Phase 3 trial in Europe will commence later this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313535-biondvax-teams-nihs-niaid-mid-stage-study-flu-vaccine-candidate-mminus-001\" target=\"_blank\">BiondVax teams up the NIH's NIAID in mid-stage study of flu vaccine candidate M-001</a> (Nov. 20, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3345031\" data-linked=\"BiondVax up 3% on start of mid-stage study of flu vaccine M-001\" data-tweet=\"$BVXV - BiondVax up 3% on start of mid-stage study of flu vaccine M-001 https://seekingalpha.com/news/3345031-biondvax-up-3-on-start-of-mid-stage-study-of-flu-vaccine-mminus-001?source=tweet\" data-url=\"https://seekingalpha.com/news/3345031-biondvax-up-3-on-start-of-mid-stage-study-of-flu-vaccine-mminus-001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345024\" data-ts=\"1523462433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELH\" target=\"_blank\">CELH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345024-consumer-top-gainers-losers-of-12-00-pm-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (04/11/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products, Inc.'>RFP</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345024\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (04/11/2018)\" data-tweet=\"$CELH $CELH $LBIX-OLD - Consumer - Top Gainers / Losers as of 12:00 PM (04/11/2018) https://seekingalpha.com/news/3345024-consumer-top-gainers-losers-of-12-00-pm-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3345024-consumer-top-gainers-losers-of-12-00-pm-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345020\" data-ts=\"1523461979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBCC\" target=\"_blank\">LBCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345020-long-blockchain-lower-25_7-on-delisting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long Blockchain lower 25.7% on delisting</a></h4><ul>     <li>Long Blockchain (<a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a>) <font color='red'>-25.7%</font> shares are to be suspended on the Nasdaq at the opening of business on April 12. At issue is a market cap unable to stay above the $35M minimum requirement.</li>          <li>The company intends to apply for OTCQB Market, effective April 12. The trading symbol will remain LBCC.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17125974-long-blockchain-corp-announces-receipt-delisting-determination-nasdaq-trading-move-otc\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3345020\" data-linked=\"Long Blockchain lower 25.7% on delisting\" data-tweet=\"$LBCC - Long Blockchain lower 25.7% on delisting https://seekingalpha.com/news/3345020-long-blockchain-lower-25_7-on-delisting?source=tweet\" data-url=\"https://seekingalpha.com/news/3345020-long-blockchain-lower-25_7-on-delisting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344991\" data-ts=\"1523461343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQCL\" target=\"_blank\">HQCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344991-hanwha-q-cells-down-3-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanwha Q CELLS down 3% post Q4 results</a></h4><ul><li>Hanwha Q CELLS (<a href='https://seekingalpha.com/symbol/HQCL' title='Hanwha Q CELLS Co., Ltd.'>HQCL</a> <font color='red'>-3.7%</font>)&nbsp;reported Q4 growth of 10.4% Y/Y to $624.7M.</li><li>Q4 margins: gross&nbsp;<font color='green'>improved by 126 bps</font>&nbsp;to 8.5% and operating <font color='red'>declined by 80 bps&nbsp;</font>to -4.8%.</li><li>Expenses: operating +36% Y/Y to $83.1M (inclusive of one-time bad debt exp. of $29.8M); selling &amp; marketing +11.9% Y/Y to $31.1M; G&amp;A +121.4% Y/Y to $46.5M and R&amp;D -44% Y/Y to $6.5M.</li><li>Q1 2018 outlook: Revenue $430-450M.</li><li>FY18 Outlook: Module shipments 6-6.2K MW; Capex ~$90M and ~$37M in planned Turkey joint venture.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344866-hanwha-q-cells-reports-q4-results\" target=\"_blank\">Hanwha Q CELLS reports Q4 results</a> (April 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344991\" data-linked=\"Hanwha Q CELLS down 3% post Q4 results\" data-tweet=\"$HQCL - Hanwha Q CELLS down 3% post Q4 results https://seekingalpha.com/news/3344991-hanwha-q-cells-down-3-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3344991-hanwha-q-cells-down-3-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345018\" data-ts=\"1523461316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTG\" target=\"_blank\">BTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345018-gold-shoots-for-20-month-high-amid-geopolitical-headlines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold shoots for 20-month high amid geopolitical headlines</a></h4><ul>     <li><a href=\"https://www.marketwatch.com/story/gold-flirts-with-highest-close-in-nearly-2-years-as-political-tensions-ramp-up-2018-04-11\" target=\"_blank\">Gold prices are on track</a> for the highest settlement since August 2016, with Comex June gold <font color='green'>+1.6%</font> at $1,367.40/oz., amid a backdrop of escalating political tensions.</li><li>Gold miners are following suit, including: <a href='https://seekingalpha.com/symbol/BTG' title='B2Gold Corp.'>BTG</a> <font color='green'>+8.7%</font>, <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='green'>+5.9%</font>, <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='green'>+4.7%</font>, ABX <font color='green'>+3.7%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='green'>+3.7%</font>, <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='green'>+3.3%</font>, <a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/OR' title='Osisko Gold Royalties Ltd.'>OR</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color='green'>+2.5%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='green'>+1.7%</font>.</li><li>\"Gold is benefiting from the risk-off sentiment and because people are<br> trying to hedge against worst-case scenarios,\" <a href=\"https://www.cnbc.com/2018/04/10/gold-markets-us-cpi-fed-minutes-in-focus.html\" target=\"_blank\">says</a> Capital Economics analyst Simona Gambarini.</li>     <li>Among other precious metals, silver <font color='green'>+1.6%</font> at $16.86/oz. and platinum <font color='green'>+1.3%</font> at $945.10/oz.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares UltraShort Silver ETF'>ZSL</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott Junior Gold Miners ETF'>SGDJ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/DBS' title='Invesco DB Silver ETF'>DBS</a>, <a href='https://seekingalpha.com/symbol/PTM' title='UBS ETRACS CMCI Long Platinum Total Return ETN'>PTM</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/GOAU' title='U.S. Global GO GOLD and Precious Metal Miners ETF'>GOAU</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/PGM-OLD' title='iPath DJ UBS Platinum Trust Sub-Index ETN'>PGM-OLD</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/USV' title='UBS ETRACS CMCI Silver Total Return ETN'>USV</a>, <a href='https://seekingalpha.com/symbol/SHNY' title='Direxion Daily Silver Miners Index Bull 2x Shares ETF'>SHNY</a>, <a href='https://seekingalpha.com/symbol/MELT' title='Direxion Daily Gold Miners Index Bear 1x Shares ETF'>MELT</a>, <a href='https://seekingalpha.com/symbol/DULL' title='Direxion Daily Silver Miners Index Bear 2x Shares ETF'>DULL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3345018\" data-linked=\"Gold shoots for 20-month high amid geopolitical headlines\" data-tweet=\"$BTG $BTG $AUY - Gold shoots for 20-month high amid geopolitical headlines https://seekingalpha.com/news/3345018-gold-shoots-for-20-month-high-amid-geopolitical-headlines?source=tweet\" data-url=\"https://seekingalpha.com/news/3345018-gold-shoots-for-20-month-high-amid-geopolitical-headlines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345015\" data-ts=\"1523460779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345015-morgan-stanley-starts-globalstar-equal-weight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley starts Globalstar at Equal Weight</a></h4><ul>   <li>Morgan Stanley is in with a new Equal-Weight rating on Globalstar (<a href=\"http://seekingalpha.com/symbol/GSAT\" target=\"_blank\">GSAT</a> <font color='green'>+7.3%</font>), ticking up anyway to its highest point in nearly three weeks.</li>    <li>The firm has a price target at $0.70; shares are up a nickel to $0.76 today.</li>    <li>On a steady decline, shares are <font color='red'>down 45.6%</font> YTD and <font color='red'>down 56%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345015\" data-linked=\"Morgan Stanley starts Globalstar at Equal Weight\" data-tweet=\"$GSAT - Morgan Stanley starts Globalstar at Equal Weight https://seekingalpha.com/news/3345015-morgan-stanley-starts-globalstar-equal-weight?source=tweet\" data-url=\"https://seekingalpha.com/news/3345015-morgan-stanley-starts-globalstar-equal-weight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345010\" data-ts=\"1523460778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAYN\" target=\"_blank\">LAYN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345010-layne-christensen-down-2-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Layne Christensen down 2% post Q4 results</a></h4><ul><li>Layne Christensen (<a href='https://seekingalpha.com/symbol/LAYN' title='Layne Christensen Company'>LAYN</a> <font color='red'>-1.7%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/3973180\" target=\"_blank\">Q4 reports</a> total revenue of $110.4M (+10.5 Y/Y) of which, water resources was $39.5M (+9.1% Y/Y); inliner $49.9M (+8.7% Y/Y) &amp; mineral services $21M (+16.7% Y/Y).</li><li>Net income for Q4 was $2.7M (+109.3 Y/Y); adjusted EBITDA of $5.5M (+231% Y/Y).</li><li>Cash &amp; equivalents $32M (-53% Y/Y); total debt of $166.1M (+2.2% Y/Y); total liquidity of $107.5M &amp; total backlog was $178.6M (+7.2% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344794-layne-christensen-eps-0_13\" target=\"_blank\">Layne Christensen EPS of $0.13</a> (April 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3345010\" data-linked=\"Layne Christensen down 2% post Q4 results\" data-tweet=\"$LAYN - Layne Christensen down 2% post Q4 results https://seekingalpha.com/news/3345010-layne-christensen-down-2-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3345010-layne-christensen-down-2-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345016\" data-ts=\"1523460371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345016-applied-optoelectronicsplus-10-following-rosenblatt-commentary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Optoelectronics +10% Following Rosenblatt Commentary</a></h4><ul>     <li>Applied Optoelectronics (<a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='green'>+10.6%</font>) soared more than 10% in morning trade after analysts from Rosenblatt Securities said the company has regained market share at key clients thanks to weakness from competitors.</li>     <li>According to Rosenblatt analyst Jun Zhang, the firm&rsquo;s expert on the Chinese tech market, it is possible that hyperscale price drops and Huawei and ZTE pulling in orders could lead to positive benefits for Applied Opto.</li><li><a href=\"https://www.zacks.com/stock/news/298844/why-is-applied-opto-aaoi-stock-soaring-today\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3345016\" data-linked=\"Applied Optoelectronics +10% Following Rosenblatt Commentary\" data-tweet=\"$AAOI - Applied Optoelectronics +10% Following Rosenblatt Commentary https://seekingalpha.com/news/3345016-applied-optoelectronicsplus-10-following-rosenblatt-commentary?source=tweet\" data-url=\"https://seekingalpha.com/news/3345016-applied-optoelectronicsplus-10-following-rosenblatt-commentary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345005\" data-ts=\"1523458856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBAY\" target=\"_blank\">CBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345005-healthcare-top-5-gainers-losers-of-11-00-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/11/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/APVO' title='Aptevo Therapeutics Inc.'>APVO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NVLN' title='Novelion Therapeutics, Inc.'>NVLN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma'>NTEC</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ALOG' title='Analogic Corporation'>ALOG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/NCNA' title='NuCana plc'>NCNA</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345005\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/11/2018)\" data-tweet=\"$CBAY $CBAY $APVO - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/11/2018) https://seekingalpha.com/news/3345005-healthcare-top-5-gainers-losers-of-11-00-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3345005-healthcare-top-5-gainers-losers-of-11-00-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345002\" data-ts=\"1523458452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345002-fcc-filing-points-to-new-version-of-snap-spectacles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FCC filing points to new version of Snap Spectacles</a></h4><ul>   <li>A new version of Snap (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color='green'>+2.6%</font>) Spectacles may be nearer after an <a href=\"http://variety.com/2018/digital/news/snap-spectacles-002-1202750097/\" target=\"_blank\">FCC filing</a> from the company for a \"wearable video camera.\"</li>    <li><i>Variety</i> notes the heavily redacted filing from late yesterday.</li>    <li>Reports in early March had the company planning a <a href=\"https://seekingalpha.com/news/3336129-cheddar-snap-planning-second-third-versions-spectacles-glasses\" target=\"_blank\">second and even third version</a> of the camera-fitted glasses, despite disappointing uptake and a $40M loss for the first version.</li>    <li>One key change appears to be support of faster Wi-Fi with the 802.11ac standard, and perhaps a redesigned frame with an electronic FCC ID label rather than an ID label on the inside of the temples.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345002\" data-linked=\"FCC filing points to new version of Snap Spectacles\" data-tweet=\"$SNAP - FCC filing points to new version of Snap Spectacles https://seekingalpha.com/news/3345002-fcc-filing-points-to-new-version-of-snap-spectacles?source=tweet\" data-url=\"https://seekingalpha.com/news/3345002-fcc-filing-points-to-new-version-of-snap-spectacles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345001\" data-ts=\"1523458168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HL\" target=\"_blank\">HL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345001-hecla-miningplus-2-following-q1-production-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hecla Mining +2% following Q1 production results</a></h4><ul>     <li>Hecla Mining (<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a> <font color='green'>+2.2%</font>) is higher after reporting <a href=\"https://seekingalpha.com/pr/17126012-hecla-reports-2_5-million-ounces-silver-57808-ounces-gold-production-first-quarter-2018\" target=\"_blank\">Q1 silver production of 2.5M oz.</a>, down 25% from the year-ago quarter, and gold production of 57.8K oz., up 3% Y/Y.</li>     <li>Nearly all of the reduced silver production is attributed to the ongoing strike by unionized employees at the Lucky Friday mine in Idaho.</li>     <li>HL says the Casa Berardi mine produced nearly 40.2K oz. of gold during Q1, up 12% Y/Y, with the mill operating at a quarterly record average of 3,873&nbsp;tons/day.</li>     <li>Q1 silver equivalent production totaled 10.7M oz., and gold equivalent production was 134.9K oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3345001\" data-linked=\"Hecla Mining +2% following Q1 production results\" data-tweet=\"$HL - Hecla Mining +2% following Q1 production results https://seekingalpha.com/news/3345001-hecla-miningplus-2-following-q1-production-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3345001-hecla-miningplus-2-following-q1-production-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3345000\" data-ts=\"1523458065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3345000-stocks-brush-off-war-worry\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks brush off war worry</a></h4><ul><li>The averages opened nicely lower after the president threatened Russia and Syria in a tweet this morning. They've reversed since, with the Nasdaq now&nbsp;<font color='green'>higher by 0.2%</font>, and the S&amp;P 500 and Dow just marginally in the red.</li><li>Oil has trimmed some of its large early gain, now&nbsp;<font color='green'>up 0.9</font>% to $66.12 per barrel.</li><li>The 10-year Treasury yield is down 2.2 basis points to 2.78%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3345000\" data-linked=\"Stocks brush off war worry\" data-tweet=\"Stocks brush off war worry https://seekingalpha.com/news/3345000-stocks-brush-off-war-worry?source=tweet\" data-url=\"https://seekingalpha.com/news/3345000-stocks-brush-off-war-worry\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344998\" data-ts=\"1523457994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344998-health-insurance-innovations-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Insurance Innovations up 6%</a></h4><ul><li>Insurance exchange operator Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a> <font color='green'>+6.2%</font>) is up on light volume in apparent response to a <a href=\"http://www.insurance.ca.gov/0400-news/0100-press-releases/2018/release036-18.cfm\" target=\"_blank\">multistate settlement</a> with private insurer HCC Life Insurance Company.</li><li>HCC has agreed to pay $5M to settle the examination which revealed certain deficiencies in its marketing of short-term health insurance policies, an approach that enables sellers and buyers to skirt the minimum coverage requirements (and higher relative cost) under the Affordable Care Act &#40;ACA&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344998\" data-linked=\"Health Insurance Innovations up 6%\" data-tweet=\"$HIIQ - Health Insurance Innovations up 6% https://seekingalpha.com/news/3344998-health-insurance-innovations-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3344998-health-insurance-innovations-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344990\" data-ts=\"1523457130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTG\" target=\"_blank\">BTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344990-b2goldplus-7-after-reporting-record-q1-gold-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B2Gold +7% after reporting record Q1 gold production</a></h4><ul>     <li>B2Gold (<a href='https://seekingalpha.com/symbol/BTG' title='B2Gold Corp.'>BTG</a> <font color='green'>+7.3%</font>) is sharply higher after reporting <a href=\"https://seekingalpha.com/pr/17126018-b2gold-reports-record-first-quarter-gold-production-revenue-2018-quarterly-gold-production\" target=\"_blank\">record Q1 gold production</a> of nearly 240K oz., up 81% Y/Y and 7% above budget, citing continued  strong performances of the Fekola mine in Mali, Masbate mine in the Philippines and the Otjikoto mine in Namibia.</li>     <li>Q1 consolidated gold revenue of $344.3M also is a quarterly record and a 135% Y/Y increase, as the average price was $1,325/oz.</li>     <li>For FY 2018, with the planned first full year of production from the Fekola mine, BTG forecasts consolidated gold production of 910K-950K oz. at all-in sustaining costs of $780-$830/oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344990\" data-linked=\"B2Gold +7% after reporting record Q1 gold production\" data-tweet=\"$BTG - B2Gold +7% after reporting record Q1 gold production https://seekingalpha.com/news/3344990-b2goldplus-7-after-reporting-record-q1-gold-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3344990-b2goldplus-7-after-reporting-record-q1-gold-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344988\" data-ts=\"1523457126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344988-acadia-pharma-up-6-on-fda-ok-on-risk-disclosures-for-nuplazid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia Pharma up 6% on FDA OK on risk disclosures for Nuplazid</a></h4><ul><li>Acadia Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='green'>+5.7%</font>) is up on modestly higher volume in response to the <a href=\"http://www.sandiegouniontribune.com/business/biotech/sd-me-acadia-fda-response-20180410-story.html\" target=\"_blank\">news </a>that the FDA stated that existing risk disclosures for Parkinson's med Nuplazid (pimavanserin) are adequate so no changes to the existing warnings are necessary.</li><li>Two days ago, shares sold off after CNN reported a high number of deaths in treated patients.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344387-acadia-pharma-17-percent-premarket-nuplazid-safety-concerns\" target=\"_blank\">Acadia Pharma down 17% premarket on Nuplazid safety concerns</a> (April 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344988\" data-linked=\"Acadia Pharma up 6% on FDA OK on risk disclosures for Nuplazid\" data-tweet=\"$ACAD - Acadia Pharma up 6% on FDA OK on risk disclosures for Nuplazid https://seekingalpha.com/news/3344988-acadia-pharma-up-6-on-fda-ok-on-risk-disclosures-for-nuplazid?source=tweet\" data-url=\"https://seekingalpha.com/news/3344988-acadia-pharma-up-6-on-fda-ok-on-risk-disclosures-for-nuplazid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344989\" data-ts=\"1523457100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344989-factordaily-amazon-will-offer-up-to-2b-breakup-fee-to-flipkart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FactorDaily: Amazon will offer up to $2B breakup fee to Flipkart</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) has reportedly offered a $1B to $2B breakup fee during talks to acquire a significant stake in Flipkart, according to <a href=\"https://factordaily.com/amazon-breakup-fee-flipkart-walmart/\" target=\"_blank\">FactorDaily sources</a>.</li><li>               A breakup fee is paid to the other party (in this case, Flipkart) if the deal doesn&rsquo;t close or the other side (Amazon) backs out of the talks.&nbsp;</li><li>               Amazon&rsquo;s offer for the Indian e-commerce giant comes as <a href=\"https://timesofindia.indiatimes.com/business/india-business/amazon-may-rival-walmart-for-buying-stake-in-flipkart/articleshow/63621181.cms\" target=\"_blank\">Walmart was entering advanced talks</a> for a majority stake in Flipkart, which has an $18B to $20B valuation.&nbsp;</li><li>               In 2016, Amazon <a href=\"https://www.cnbc.com/2016/06/08/amazon-plans-3-billion-investment-in-india-to-challenge-flipkart-snapdeal.html\" target=\"_blank\">announced plans</a> to invest $3B in the Indian market to better take on Flipkart.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='green'>up 0.8%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343531-amazon-launch-competing-bid-indias-flipkart-report\" target=\"_blank\">Amazon could launch competing bid for India's Flipkart: report</a> (April 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344989\" data-linked=\"FactorDaily: Amazon will offer up to $2B breakup fee to Flipkart\" data-tweet=\"$AMZN - FactorDaily: Amazon will offer up to $2B breakup fee to Flipkart https://seekingalpha.com/news/3344989-factordaily-amazon-will-offer-up-to-2b-breakup-fee-to-flipkart?source=tweet\" data-url=\"https://seekingalpha.com/news/3344989-factordaily-amazon-will-offer-up-to-2b-breakup-fee-to-flipkart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344982\" data-ts=\"1523455531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344982-omeros-frees-up-45m-in-new-capital-via-amendment-to-credit-facility-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros frees up $45M in new capital via amendment to credit facility; shares up 9%</a></h4><ul><li>Omeros (<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+8.9%</font>) <a href=\"https://seekingalpha.com/pr/17126635-omeros-announces-amendment-credit-facility\" target=\"_blank\">announces </a>a change to its existing credit facility with certain affiliates of investment firm CRG LP under which it has access to as much as $45M in new borrowings. The expanded credit limit was enabled by the reduction of the minimum market cap/loan balance ratio from 6.4x to 3.0x. It may borrow the funds on or before May 20.</li><li>In conjunction with the amendment, the company will issue five-year warrants to the lenders to purchase up to 200K shares of stock at $23 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344982\" data-linked=\"Omeros frees up $45M in new capital via amendment to credit facility; shares up 9%\" data-tweet=\"$OMER - Omeros frees up $45M in new capital via amendment to credit facility; shares up 9% https://seekingalpha.com/news/3344982-omeros-frees-up-45m-in-new-capital-via-amendment-to-credit-facility-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3344982-omeros-frees-up-45m-in-new-capital-via-amendment-to-credit-facility-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344977\" data-ts=\"1523455251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QNST\" target=\"_blank\">QNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344977-quinstreetminus-15_5-short-seller-kerrisdale-takes-aim\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QuinStreet -15.5% as short seller Kerrisdale takes aim</a></h4><ul>   <li>Online marketing firm QuinStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/QNST' title='QuinStreet, Inc.'>QNST</a>) is <font color='red'>15.5% lower</font> as short seller Kerrisdale <a href=\"https://www.kerrisdalecap.com/wp-content/uploads/2018/04/QuinStreet-Inc.-QNST.pdf\" target=\"_blank\">puts it in the crosshairs</a> after a price run-up.</li>    <li>The firm is an \"outdated online marketing company with a bad business model benefiting from fake web traffic,\" Kerrisdale says.</li>    <li>Looking at comps from private competitors with superior business models, the firm says, QuinStreet should be trading around $5-$7/share (it's at $10.40 now). \"But if, as we believe, a significant amount of its business is based on fake traffic, there's no floor,\" the firm writes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344977\" data-linked=\"QuinStreet -15.5% as short seller Kerrisdale takes aim\" data-tweet=\"$QNST - QuinStreet -15.5% as short seller Kerrisdale takes aim https://seekingalpha.com/news/3344977-quinstreetminus-15_5-short-seller-kerrisdale-takes-aim?source=tweet\" data-url=\"https://seekingalpha.com/news/3344977-quinstreetminus-15_5-short-seller-kerrisdale-takes-aim\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344972\" data-ts=\"1523454762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZS\" target=\"_blank\">ZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344972-ubs-initiates-zscaler-7-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS initiates Zscaler at 7% upside</a></h4><ul><li>        UBS<a href=\"https://www.streetinsider.com/New+Coverage/UBS+Starts+Zscaler+%28ZS%29+at+Neutral/14044041.html\" target=\"_blank\"> initiates</a> coverage on Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler'>ZS</a>) with a Neutral Rating and a $30 price target.</li><li>                  Target represents a 7% upside to yesterday&rsquo;s close.    </li><li>               Zscaler shares are<font color='green'> up 1%</font>&nbsp;to $28.34.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344972\" data-linked=\"UBS initiates Zscaler at 7% upside\" data-tweet=\"$ZS - UBS initiates Zscaler at 7% upside https://seekingalpha.com/news/3344972-ubs-initiates-zscaler-7-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3344972-ubs-initiates-zscaler-7-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344970\" data-ts=\"1523454435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344970-cnbc-redstone-likely-to-fire-moonves-no-cbs-viacom-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Redstone likely to fire Moonves if no CBS/Viacom deal</a></h4><ul>   <li>Shari Redstone is <a href=\"https://www.cnbc.com/2018/04/11/redstone-likely-to-replace-moonves-as-head-of-cbs-if-no-deal-with-viacom-sources-say.html\" target=\"_blank\">likely to fire</a> <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> chief Les Moonves if the company doesn't end up re-merging with Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='red'>-1.7%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>-0.9%</font>), CNBC is reporting.</li>    <li>CBS shares are <font color='red'>1.9% lower</font>.</li>    <li>She'd also sub out the CBS board, according to the report.</li><li>CBS is set to make another offer soon that may also come up short of Viacom's wishes, the network says.</li>    <li>Moonves has become central to the power struggle over the potential deal, as Redstone -- whose National Amusements controls both companies -- wants to see Viacom chief Bob Bakish as second-in-command at the combined company, while Moonves would prefer his lieutenant Joe Ianniello.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344515-bloomberg-large-cbs-shareholder-urges-company-steer-clear-viacom\" target=\"_blank\">Bloomberg: Large CBS shareholder urges company to steer clear of Viacom</a> (Apr. 09 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344398-viacoms-request-get-41_5-percent-stake-cbs-combo\" target=\"_blank\">Viacom's request would get it 41.5% stake in CBS combo</a> (Apr. 09 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343337-cnbc-viacom-cbs-turning-potential-moonves-second-command\" target=\"_blank\">CNBC: Viacom/CBS turning on potential Moonves second-in-command</a> (Apr. 03 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344970\" data-linked=\"CNBC: Redstone likely to fire Moonves if no CBS/Viacom deal\" data-tweet=\"$CBS $VIAC $VIA - CNBC: Redstone likely to fire Moonves if no CBS/Viacom deal https://seekingalpha.com/news/3344970-cnbc-redstone-likely-to-fire-moonves-no-cbs-viacom-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3344970-cnbc-redstone-likely-to-fire-moonves-no-cbs-viacom-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344963\" data-ts=\"1523453840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEG\" target=\"_blank\">EYEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344963-eyegate-nabs-u-s-patent-covering-iontophoretic-contact-lens-shares-up-29\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyeGate nabs U.S. patent covering iontophoretic contact lens; shares up 29%</a></h4><ul><li>The USPTO has issued a new <a href=\"https://seekingalpha.com/pr/17126391-eyegate-issued-new-patent-iontophoretic-contact-lens-technology\" target=\"_blank\">patent </a>to EyeGate Pharmaceuticals (<a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='green'>+28.8%</font>) covering the utility of its iontophoretic contact lens. Specifically, the patent relates to a multi-layer contact lens for ocular therapy, comprising a reservoir adapted to contain an electrically-charged therapeutic compound and an electrode providing iontophoretic current to the charged compound to propel it into the ocular tissue.</li><li>The company says the lens provides an easy, potentially improved technique for delivery of therapeutics to the retina.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344963\" data-linked=\"EyeGate nabs U.S. patent covering iontophoretic contact lens; shares up 29%\" data-tweet=\"$EYEG - EyeGate nabs U.S. patent covering iontophoretic contact lens; shares up 29% https://seekingalpha.com/news/3344963-eyegate-nabs-u-s-patent-covering-iontophoretic-contact-lens-shares-up-29?source=tweet\" data-url=\"https://seekingalpha.com/news/3344963-eyegate-nabs-u-s-patent-covering-iontophoretic-contact-lens-shares-up-29\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344962\" data-ts=\"1523453519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344962-ericsson-down-berenberg-favors-nokia-in-euro-telecoms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson down as Berenberg favors Nokia in Euro telecoms</a></h4><ul>   <li>Ericsson (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a>) is <font color='red'>down 1.6%</font> in U.S. trading after a launch at Berenberg comes out preferring Nokia (<a href=\"http://seekingalpha.com/symbol/NOK\" target=\"_blank\">NOK</a> <font color='green'>+0.4%</font>) in a head-to-head comparison of networking firms coming out of restructurings.</li>    <li>The firm has started Ericsson at Hold while launching Nokia at Buy, with a cautiously optimistic view on the European telecom subsector.</li>    <li>Investments in cloud edge and optical core transport networks are likely bigger drivers of the market than 5G, the firm says. (h/t Bloomberg)</li>    <li>Berenberg has a price target of &euro;5.50 on Nokia, implying 22% upside, and a target of 55 kronor on Ericsson, implying 5% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344962\" data-linked=\"Ericsson down as Berenberg favors Nokia in Euro telecoms\" data-tweet=\"$ERIC $ERIC $NOK - Ericsson down as Berenberg favors Nokia in Euro telecoms https://seekingalpha.com/news/3344962-ericsson-down-berenberg-favors-nokia-in-euro-telecoms?source=tweet\" data-url=\"https://seekingalpha.com/news/3344962-ericsson-down-berenberg-favors-nokia-in-euro-telecoms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344960\" data-ts=\"1523453322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTEC\" target=\"_blank\">NTEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344960-intec-pharma-prices-stock-offering-5_25-shares-down-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intec Pharma prices stock offering at $5.25; shares down 16% premarket</a></h4><ul><li>Intec Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma'>NTEC</a>) <a href=\"https://seekingalpha.com/pr/17126552-intec-pharma-announces-pricing-35_4-million-public-offering-ordinary-shares\" target=\"_blank\">prices </a>its public offering of 6.75M ordinary shares at $5.25 per share. Underwriters over-allotment is an additional 1M shares. Closing date is April 13.</li><li>Shares are down&nbsp;<font color='red'>16%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344960\" data-linked=\"Intec Pharma prices stock offering at $5.25; shares down 16% premarket\" data-tweet=\"$NTEC - Intec Pharma prices stock offering at $5.25; shares down 16% premarket https://seekingalpha.com/news/3344960-intec-pharma-prices-stock-offering-5_25-shares-down-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3344960-intec-pharma-prices-stock-offering-5_25-shares-down-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344959\" data-ts=\"1523453097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344959-bed-bath-beyond-poised-for-earnings-volatility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond poised for earnings volatility</a></h4><ul> <li>Shares of Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) could see a wild ride after the retailer reports earnings today after the bell.</li> <li>Bloomberg reports that call open interest is up 53% since March 12 and put open interest is 31% higher. The options activity implies a 12% move in BBBY's share price after earnings, which would double the normal post-earnings swing.</li> <li>Bed Bath &amp; Beyond is expected to report revenue of $3.68B and EPS of $1.39.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344959\" data-linked=\"Bed Bath &amp; Beyond poised for earnings volatility\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond poised for earnings volatility https://seekingalpha.com/news/3344959-bed-bath-beyond-poised-for-earnings-volatility?source=tweet\" data-url=\"https://seekingalpha.com/news/3344959-bed-bath-beyond-poised-for-earnings-volatility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344958\" data-ts=\"1523452886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344958-premarket-gainers-of-9-05-04-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (04/11/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+23%</font>&nbsp;on Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) <a href=\"https://seekingalpha.com/news/3344944-virnetx-plus-28_1-percent-apple-patent-victory\" target=\"_blank\">patent victory</a>.</li>     <li><a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+19%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3344949-cymabay-11-percent-premarket-positive-mid-stage-seladelpar-data\" target=\"_blank\">positive</a> mid-stage seladelpar data.</li>     <li><a href='https://seekingalpha.com/symbol/APVO' title='Aptevo Therapeutics Inc.'>APVO</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='green'>+7%</font>&nbsp;on production <a href=\"https://seekingalpha.com/pr/17126037-pretium-resources-inc-brucejack-mine-q1-2018-production-update\" target=\"_blank\">results</a>.</li>     <li><a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17126289-inovio-awarded-56-million-cepi-advance-dna-vaccines-lassa-fever-mers\" target=\"_blank\">partnership</a> under which the company will develop vaccine candidates against Lassa fever and Middle East Respiratory Syndrome.</li>     <li><a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+6%</font>&nbsp;as lead candidate <a href=\"https://seekingalpha.com/news/3344906-arrowheads-lead-candidate-shows-encouraging-action-hbv-extension-study-shares-9-percent\" target=\"_blank\">shows</a> encouraging action in HBV extension study.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344958\" data-linked=\"Premarket Gainers as of 9:05 am (04/11/2018)\" data-tweet=\"$VHC $VHC $AAPL - Premarket Gainers as of 9:05 am (04/11/2018) https://seekingalpha.com/news/3344958-premarket-gainers-of-9-05-04-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344958-premarket-gainers-of-9-05-04-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344957\" data-ts=\"1523452756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344957-inovio-pharma-secures-56m-in-funding-for-lassa-fever-and-mers-vaccines-shares-up-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio Pharma secures $56M in funding for Lassa fever and MERS vaccines; shares up 6% premarket</a></h4><ul><li>Inovio Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17126289-inovio-awarded-56-million-cepi-advance-dna-vaccines-lassa-fever-mers\" target=\"_blank\">announcement </a>that the Coalition for Epidemic Preparedness Innovations &#40;CEPI&#41; will provide up the $56M in funding to support the development of vaccines against Lassa fever (INO-4500) and Middle East Respiratory Syndrome &#40;MERS&#41; (INO-4700) through Phase 2.</li><li>The agreement, providing funding over a five-year period, also includes options to establish investigational stockpiles of both vaccines.</li><li>CEPI is a partnership between public, private, philanthropic and civil organizations founded in Davos last year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344719-geovax-awarded-nih-grant-support-development-lassa-virus-vaccine-shares-8-percent\" target=\"_blank\">GeoVax awarded NIH grant to support development of Lassa virus vaccine; shares up 8%</a> (April 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344957\" data-linked=\"Inovio Pharma secures $56M in funding for Lassa fever and MERS vaccines; shares up 6% premarket\" data-tweet=\"$INO - Inovio Pharma secures $56M in funding for Lassa fever and MERS vaccines; shares up 6% premarket https://seekingalpha.com/news/3344957-inovio-pharma-secures-56m-in-funding-for-lassa-fever-and-mers-vaccines-shares-up-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3344957-inovio-pharma-secures-56m-in-funding-for-lassa-fever-and-mers-vaccines-shares-up-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344953\" data-ts=\"1523452263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BW\" target=\"_blank\">BW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344953-premarket-losers-of-9-05-4-11-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (4/11/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a>&nbsp;<font color='red'>-35%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3344826-babcock-and-wilcox-minus-33-percent-amending-rights-offering\" target=\"_blank\">amending</a> rights offering.</li><li><a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma'>NTEC</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3344780-intec-pharma-readies-stock-offering\" target=\"_blank\">announcing</a> public offering of ordinary shares.</li><li><a href='https://seekingalpha.com/symbol/ALOG' title='Analogic Corporation'>ALOG</a>&nbsp;<font color='red'>-13%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3344791-analogic-acquired-1_1b\" target=\"_blank\">announcing</a> merger deal.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344953\" data-linked=\"Premarket Losers as of 9:05 am (4/11/2018)\" data-tweet=\"$BW $BW $NTEC - Premarket Losers as of 9:05 am (4/11/2018) https://seekingalpha.com/news/3344953-premarket-losers-of-9-05-4-11-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344953-premarket-losers-of-9-05-4-11-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344949\" data-ts=\"1523452080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBAY\" target=\"_blank\">CBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344949-cymabay-up-11-premarket-on-positive-mid-stage-seladelpar-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CymaBay up 11% premarket on positive mid-stage seladelpar data</a></h4><ul><li>CymaBay Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a>) is up&nbsp;<font color='green'>11%</font>&nbsp;premarket on modest volume on the heels of its <a href=\"https://seekingalpha.com/pr/17126219-cymabay-announces-positive-new-12-week-26-week-results-ongoing-phase-2-study-seladelpar\" target=\"_blank\">announcement </a>of additional preliminary data from a Phase 2 clinical trial assessing seladelpar in patients with primary biliary cholangitis &#40;PBC&#41;. The results will be presented at The International Liver Congress in Paris on April 12.</li><li>The data demonstrated a treatment effect after 12 and 26 weeks of treatment. Specifically, PBC patients experienced reductions from baseline in mean alkaline phosphatase &#40;AP&#41; of up to 45% (elevated AP is a biomarker for liver disease). 29% of patients had normal AP levels at week 26.</li><li>On the safety front, seladelpar was generally safe and well-tolerated. There were six serious adverse events but none were determined to be related to the drug.</li><li>Seladelpar, an orally available PPAR&delta; agonist, is also in development for the treatment of nonalcoholic steatohepatitis &#40;NASH&#41;.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3278911-cymabays-seladelpar-shows-positive-treatment-effect-mid-stage-pbc-study-shares-ahead-17\" target=\"_blank\">CymaBay's seladelpar shows positive treatment effect in mid-stage PBC study; shares ahead 17% premarket</a> (July 17, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344949\" data-linked=\"CymaBay up 11% premarket on positive mid-stage seladelpar data\" data-tweet=\"$CBAY - CymaBay up 11% premarket on positive mid-stage seladelpar data https://seekingalpha.com/news/3344949-cymabay-up-11-premarket-on-positive-mid-stage-seladelpar-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3344949-cymabay-up-11-premarket-on-positive-mid-stage-seladelpar-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344944\" data-ts=\"1523451756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344944-virnetxplus-28_1-on-apple-patent-victory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX +28.1% on Apple patent victory</a></h4><ul><li>           A federal jury <a href=\"https://www.bloomberg.com/technology\" target=\"_blank\">rules</a> that Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) has to pay VirnetX (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>) $502.6M due to patent infringement. </li><li>           The Texas-based jury found that Apple infringed on VirnetX&rsquo;s patents for secure communications when creating FaceTime, VPN on Demand, and iMessage.  </li><li> The legal battle started in 2010 and had bounced between courts and trials. A recent jury awarded $302M in a case involving older Apple devices; a judge increased that amount to $429.7M. &nbsp; </li><li>           The Patent Trial and Appeal Board has ruled the patents invalid, which VirnetX is appealing. But if that ruling stands, the newest victory will be short-lived.  </li><li> VirnetX shares are&nbsp;<font color='green'>up 28.1%</font>&nbsp;premarket to $5.25. </li><li> Apple shares are&nbsp;<font color='red'>down 0.7%</font>&nbsp;premarket to $172.10.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3344944\" data-linked=\"VirnetX +28.1% on Apple patent victory\" data-tweet=\"$AAPL $AAPL $VHC - VirnetX +28.1% on Apple patent victory https://seekingalpha.com/news/3344944-virnetxplus-28_1-on-apple-patent-victory?source=tweet\" data-url=\"https://seekingalpha.com/news/3344944-virnetxplus-28_1-on-apple-patent-victory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344922\" data-ts=\"1523449515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBLU\" target=\"_blank\">JBLU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344922-jetblue-turns-in-efficient-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JetBlue turns in efficient month</a></h4><ul> <li>JetBlue (NASDAQ:<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a>) reports revenue passenger miles increased 7.3% in March to 4.376B.</li> <li>Capacity was up 3.3% to 4.918B available seat miles. Passengers flown were 4.7% higher during the month.</li> <li>JetBlue's load factor improved 330 bps to 89.0% in March. YTD load factor +70 bps to 84.6%.</li> <li>The company expects Q1 revenue per available seat mile to be up 6.1% Y/Y to top the prior outlook for a 3.5% to 5.5% gain.</li> <li>JBLU <font color='green'>+0.72%</font> premarket to $19.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344922\" data-linked=\"JetBlue turns in efficient month\" data-tweet=\"$JBLU - JetBlue turns in efficient month https://seekingalpha.com/news/3344922-jetblue-turns-in-efficient-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3344922-jetblue-turns-in-efficient-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344919\" data-ts=\"1523449161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344919-keybanc-positive-on-ebay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc positive on eBay</a></h4><ul> <li>KeyBanc upgrades eBay (NASDAQ:<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a>) to an Overweight rating after having the e-commerce stock set at Equalweight. Analyst Ed Yruma points to eBay's focus on retail tech and artificial intelligence as revenue drivers.</li> <li>EBay is due to report earnings on April 25.</li> <li>Shares of eBay are <font color='green'>up 0.28%</font> premarket to $39.70 vs. a 52-week trading range of $31.89 to $46.99.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3344919\" data-linked=\"KeyBanc positive on eBay\" data-tweet=\"$EBAY - KeyBanc positive on eBay https://seekingalpha.com/news/3344919-keybanc-positive-on-ebay?source=tweet\" data-url=\"https://seekingalpha.com/news/3344919-keybanc-positive-on-ebay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344906\" data-ts=\"1523448295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344906-arrowheads-lead-candidate-shows-encouraging-action-in-hbv-extension-study-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead&#39;s lead candidate shows encouraging action in HBV extension study; shares up 9% premarket</a></h4><ul><li>Arrowhead Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a>) <a href=\"https://seekingalpha.com/pr/17126152-arrowhead-pharmaceuticals-presents-arcminus-520-clinical-data-international-liver-congress\" target=\"_blank\">announces </a>positive data on lead candidate ARC-520 from the Heparc-2001 multi-dose extension study. The results will be presented at The International Liver Congress in Paris on April 13.</li><li>Eight patients with chronic hepatitis B virus &#40;HBV&#41; infection received up to nine doses of ARC-520 (4 mg/kg) once every four weeks with daily entecavir &#40;ETV&#41;. Patients continued receiving daily ETV for an additional 12 months.</li><li>One e-antigen-negative patient serocleared surface antigen (HBsAg) after ARC-520.</li><li>Mild changes in the liver enzyme ALT off ARC-520 therapy coincided with sustained host responses in two of three e-antigen-positive patients and two of five e-antigen-negative patients. The presence of e-antigen is an indicator of active viral replication.</li><li>Multiple doses of ARC-520 produced surface antigen reductions in all patients by as much as 5.3 Log10 (more than a 99% reduction). The presence of surface antigen indicates acute or chronic HBV infection.</li><li>A single dose of ARC-520 + ETV reduced surface antigen for up to 44 weeks.</li><li>ARC-520 is an RNAi therapeutic that intervenes upstream of the reverse transcription process where current standard-of-care nucleotide and nucleoside analogs act and is designed to silence the production of all HBV gene products.</li><li>Shares are up&nbsp;<font color='green'>9%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316613-arrowhead-pharmas-hbv-candidate-acrminus-520-shows-positive-effect-mid-stage-study-shares-11\" target=\"_blank\">Arrowhead Pharma's HBV candidate ACR-520 shows positive effect in mid-stage study; shares up 11% premarket</a> (Dec. 6, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344906\" data-linked=\"Arrowhead&#39;s lead candidate shows encouraging action in HBV extension study; shares up 9% premarket\" data-tweet=\"$ARWR - Arrowhead&#39;s lead candidate shows encouraging action in HBV extension study; shares up 9% premarket https://seekingalpha.com/news/3344906-arrowheads-lead-candidate-shows-encouraging-action-in-hbv-extension-study-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3344906-arrowheads-lead-candidate-shows-encouraging-action-in-hbv-extension-study-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344913\" data-ts=\"1523448229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344913-jefferies-sees-fair-value-on-mattel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies sees fair value on Mattel</a></h4><ul> <li>Jefferies sees many of the risks on Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) as now baked into the toy stock's share price.</li> <li>While analyst Stephanie Wissink still sees the Toys \"R\" Us liquidation, a sales recovery pushout and lack of portfolio contribution to value creation as risks to Mattel, she moves Mattel to a Hold rating from Underperform.</li> <li>Jefferies keeps a price target of $13 on Mattel.</li> <li>Shares of Mattel are <font color='green'>up 1.55%</font> to $13.73 in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344913\" data-linked=\"Jefferies sees fair value on Mattel\" data-tweet=\"$MAT - Jefferies sees fair value on Mattel https://seekingalpha.com/news/3344913-jefferies-sees-fair-value-on-mattel?source=tweet\" data-url=\"https://seekingalpha.com/news/3344913-jefferies-sees-fair-value-on-mattel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344911\" data-ts=\"1523448179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344911-fastenal-sinks-after-meeting-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal sinks after meeting expectations</a></h4><ul><li>Matching expectations, net income rose almost 30% to $174.3M, or $0.61 per share vs. the same period a year ago.</li><li>Daily sales of fastener products grew 11.8% in total, of which 3.7 percentage points were attributable to the acquired Mansco business.</li><li>Employee, occupancy and selling transportation-related expenses increased 14.4%, 7.7% and 12.3%, respectively.</li><li><a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color='red'>-4.4%</font> premarket</li><li><a href=\"https://seekingalpha.com/news/3344871-fastenal-eps-line-beats-revenue\" target=\"_blank\">Q1 results</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344911\" data-linked=\"Fastenal sinks after meeting expectations\" data-tweet=\"$FAST - Fastenal sinks after meeting expectations https://seekingalpha.com/news/3344911-fastenal-sinks-after-meeting-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3344911-fastenal-sinks-after-meeting-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344904\" data-ts=\"1523447997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344904-therapeuticsmd-enters-label-negotiations-for-txminus-004hr\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD enters into label negotiations for TX-004HR</a></h4><ul> <li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) has <a href=\"https://seekingalpha.com/pr/17126053-therapeuticsmd-enters-label-negotiations-txminus-004hr\" target=\"_blank\">entered</a> into negotiations       with the FDA regarding the proposed       label for TX-004HR, an investigational applicator-free       estradiol vaginal softgel capsule for the treatment of       moderate-to-severe vaginal pain during sexual intercourse (dyspareunia).</li><li>The Company may not provide updates with respect to label       negotiations prior to the agency's action date of May 29.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3344904\" data-linked=\"TherapeuticsMD enters into label negotiations for TX-004HR\" data-tweet=\"$TXMD - TherapeuticsMD enters into label negotiations for TX-004HR https://seekingalpha.com/news/3344904-therapeuticsmd-enters-label-negotiations-for-txminus-004hr?source=tweet\" data-url=\"https://seekingalpha.com/news/3344904-therapeuticsmd-enters-label-negotiations-for-txminus-004hr\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344907\" data-ts=\"1523447838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATUS\" target=\"_blank\">ATUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344907-altice-usa-initiated-29-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice USA initiated at 29% upside</a></h4><ul><li>        Evercore ISI <a href=\"https://www.streetinsider.com/New+Coverage/Evercore+ISI+Starts+Altice-USA+%28ATUS%29+at+Outperform/14043411.html\" target=\"_blank\">initiates</a> Altice USA (NYSE:<a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA'>ATUS</a>) with an Outperform rating and $24 price target.</li><li>                  Price target represents a 29% upside to yesterday&rsquo;s close. &nbsp;&nbsp;   </li><li>               Altice shares are flat premarket at $18.67.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344907\" data-linked=\"Altice USA initiated at 29% upside\" data-tweet=\"$ATUS - Altice USA initiated at 29% upside https://seekingalpha.com/news/3344907-altice-usa-initiated-29-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3344907-altice-usa-initiated-29-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344902\" data-ts=\"1523447155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITL\" target=\"_blank\">MITL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344902-national-bank-downgrades-mitel-networks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Bank downgrades Mitel Networks</a></h4><ul><li>        National Bank Financial downgrades Mitel Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/MITL' title='Mitel Networks Corporation'>MITL</a>) from Outperform to Sector Perform.</li><li>               Source: Briefing.com.&nbsp;</li><li>               Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=MITL:NSQ\" target=\"_blank\">recommendations</a>: 3 Buy, 4 Outperform, and 2 Hold.&nbsp;</li><li>               Median price target: $11.50.&nbsp;</li><li>               Mitel Networks shares are&nbsp;<font color='red'>down 0.7%</font>&nbsp;premarket to $9.61.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344902\" data-linked=\"National Bank downgrades Mitel Networks\" data-tweet=\"$MITL - National Bank downgrades Mitel Networks https://seekingalpha.com/news/3344902-national-bank-downgrades-mitel-networks?source=tweet\" data-url=\"https://seekingalpha.com/news/3344902-national-bank-downgrades-mitel-networks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344898\" data-ts=\"1523446653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNT\" target=\"_blank\">FTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344898-fortinetminus-2_7-on-morgan-stanley-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortinet -2.7% on Morgan Stanley downgrade</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+Fortinet+%28FTNT%29+to+Equalweight/14042993.html\" target=\"_blank\">downgrades</a> Fortinet (NASDAQ:<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>) from Overweight to Equal Weight.</li><li>               Price target: $53, a 6% downside to yesterday&rsquo;s close.&nbsp;</li><li>               Fortinet shares are&nbsp;<font color='red'>down 2.7%</font>&nbsp;premarket to $54.69.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344898\" data-linked=\"Fortinet -2.7% on Morgan Stanley downgrade\" data-tweet=\"$FTNT - Fortinet -2.7% on Morgan Stanley downgrade https://seekingalpha.com/news/3344898-fortinetminus-2_7-on-morgan-stanley-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3344898-fortinetminus-2_7-on-morgan-stanley-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344897\" data-ts=\"1523446527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344897-losses-for-russia-trump-warns-over-syria\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More losses for Russia as Trump warns over Syria</a></h4><ul><li>\"Get ready Russia,&nbsp; because [missiles] will be coming, nice and new and, smart,\"<a href=\"https://twitter.com/realDonaldTrump/status/984022625440747520\" target=\"_blank\"> tweets the President</a> this morning. \"You shouldn&rsquo;t be partners with a Gas Killing Animal who kills his people and enjoys it!\"</li><li>The ruble is<font color='red'> lower by 3.2%</font>&nbsp;vs. the dollar. <a href='https://seekingalpha.com/symbol/RSX' title='VanEck Vectors Russia ETF'>RSX</a>&nbsp;<font color='red'>-3.8%</font>&nbsp;premarket</li><li>ETFs: <a href='https://seekingalpha.com/symbol/RSX' title='VanEck Vectors Russia ETF'>RSX</a>, <a href='https://seekingalpha.com/symbol/RUSL' title='Direxion Daily Russia Bull 3x Shares ETF'>RUSL</a>, <a href='https://seekingalpha.com/symbol/RUSS' title='Direxion Daily Russia Bear 3x Shares ETF'>RUSS</a>, <a href='https://seekingalpha.com/symbol/ERUS' title='iShares MSCI Russia Capped ETF'>ERUS</a>, <a href='https://seekingalpha.com/symbol/RSXJ' title='VanEck Vectors Russia Small-Cap ETF'>RSXJ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344897\" data-linked=\"More losses for Russia as Trump warns over Syria\" data-tweet=\"$RSX $RUSL $RUSS - More losses for Russia as Trump warns over Syria https://seekingalpha.com/news/3344897-losses-for-russia-trump-warns-over-syria?source=tweet\" data-url=\"https://seekingalpha.com/news/3344897-losses-for-russia-trump-warns-over-syria\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344890\" data-ts=\"1523445998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344890-bonds-on-rise-on-war-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bonds on the rise on war chatter</a></h4><ul><li>The president is making a lot of noise <a href=\"https://seekingalpha.com/news/3344884-futures-pull-back\" target=\"_blank\">about a military strike</a> on Syria in response to a supposed chemical attack ordered by Assad. The news has stock index futures<font color='red'> pulling back by about 1%</font>, and the 10-year Treasury yield down 3 basis points to 2.77%.</li><li>Up later today for bond traders to chew on will be March inflation numbers and minutes from the latest FOMC minutes.</li><li><a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.3%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-0.6%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Treasury ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/SPTL' title='SPDR Portfolio Long Term Treasury ETF'>SPTL</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344890\" data-linked=\"Bonds on the rise on war chatter\" data-tweet=\"$TLT $TBT $TMV - Bonds on the rise on war chatter https://seekingalpha.com/news/3344890-bonds-on-rise-on-war-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3344890-bonds-on-rise-on-war-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344886\" data-ts=\"1523445386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344886-mizuho-upgrades-synaptics-to-25-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho upgrades Synaptics to 25% upside</a></h4><ul><li>        Mizuho <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Mizuho+Securities+Upgrades+Synaptics+%28SYNA%29+to+Buy/14043000.html\" target=\"_blank\">upgrades</a> Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) from Neutral to Buy and raises the price target from $42 to $55, a 25% upside to yesterday&rsquo;s close.</li><li>               Firm sees potential upsides in 2H that could include higher LCD iPhone mix of 50% to 60%, CoF ramp and potential LCD iPhone ramp, and TDDI growth on the year.&nbsp;</li><li>               Synaptics shares are&nbsp;<font color='green'>up 2%</font>&nbsp;premarket to $44.90.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344886\" data-linked=\"Mizuho upgrades Synaptics to 25% upside\" data-tweet=\"$SYNA - Mizuho upgrades Synaptics to 25% upside https://seekingalpha.com/news/3344886-mizuho-upgrades-synaptics-to-25-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3344886-mizuho-upgrades-synaptics-to-25-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344885\" data-ts=\"1523445377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASRAF\" target=\"_blank\">ASRAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344885-shock-result-sends-roma-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shock result sends Roma higher</a></h4><ul> <li>Shares of A.S. Roma (<a href='https://seekingalpha.com/symbol/ASRAF' title='A S Roma Spa'>OTCPK:ASRAF</a>) soar 20% in Milan trading after the Italian soccer club's shock 3-0 win against Barcelona sent it to the UEFA Champions League semi-final.</li> <li>Bookmakers had Roma at <a href=\"https://www.bloomberg.com/news/articles/2018-04-11/roma-shares-surge-after-stunning-victory-against-barcelona\" target=\"_blank\">20-1</a> odds on progressing to the lucrative next round of the Champions League.</li> <li>Despite today's rally, Roma shares are still below where they stood at the beginning of the year.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344885\" data-linked=\"Shock result sends Roma higher\" data-tweet=\"$ASRAF - Shock result sends Roma higher https://seekingalpha.com/news/3344885-shock-result-sends-roma-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3344885-shock-result-sends-roma-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":72,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}